Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Franca Belli"'
Autor:
M. G. Arena, Silvia Ileana Fattoruso, Silverio Tomao, Maddalena Barba, Domenico Sergi, Luigi Di Lauro, Laura Pizzuti, Franca Belli, G. Paoletti, Marcello Maugeri-Saccà, Patrizia Vici, Diana Giannarelli
Publikováno v:
Gastric Cancer. 17:718-724
The incorporation of docetaxel into the cisplatin and fluorouracil backbone has been demonstrated to be an active combination in metastatic gastric cancer. Nevertheless, this regimen is burdened by nonnegligible toxicity. We hypothesized that replaci
Autor:
Marcello Maugeri-Saccà, Marcella Mottolese, Franca Belli, Maddalena Barba, Domenico Sergi, Luigi Di Lauro, Carla Azzurra Amoreo, Daniele Santini, Patrizia Vici, Ruggero De Maria, Isabella Sperduti, Laura Pizzuti, Valerie Speirs
Publikováno v:
Journal of Hematology & Oncology
Background: Male breast cancer is a rare malignancy. Despite the lack of prospectively generated data from trials in either the adjuvant or metastatic setting, patients are commonly treated with hormone therapies. Much controversy exists over the use
Autor:
E. Durini, A. Amodio, Giuseppe Colucci, Francesca Conti, Salvatore Pisconti, Franca Belli, Vittorio Gebbia, Diana Giannarelli, Massimo Lopez, G. Pezzella, Nicola Gebbia, Patrizia Vici, Francesco Giotta, M. Brandi, M. R. Valerio
Publikováno v:
Journal of Clinical Oncology. 20:2689-2694
PURPOSE: This phase II multicenter trial was aimed at investigating the activity of epirubicin-vinorelbine combination as first-line chemotherapy in metastatic breast cancer patients. PATIENTS AND METHODS: Ninety-seven patients with metastatic breast
Autor:
Francesca Conti, Patrizia Vici, P. Foggi, Luigi Di Lauro, Franca Belli, A. Amodio, A. Ferraironi, Claudio Botti, Massimo Lopez, T. Gionfra, Maria Francesca Morelli
Publikováno v:
Oncology. 60:60-65
Objective: To better determine docetaxel activity in patients with well-defined anthracycline-resistant breast cancer. Methods: From October 1996, we carried out a phase II trial in 69 heavily pretreated patients with advanced breast cancer with doce
Autor:
Luigi Di Lauro, A. Amodio, Patrizia Vici, Franca Belli, Francesca Conti, Massimo Lopez, T. Gionfra
Publikováno v:
Oncology. 58:3-7
Based on preclinical data showing a synergistic activity of simultaneous administration of vinorelbine and paclitaxel, we carried out a phase II trial in previously untreated advanced breast cancer patients. Treatment consisted of vinorelbine 25 mg/m
Autor:
Marcello Maugeri-Saccà, Sara Boggia, Franca Belli, Maddalena Barba, Domenico Sergi, Diana Giannarelli, Patrizia Vici, A. Amodio, Laura Pizzuti, Luigi Di Lauro, Silvia Ileana Fattoruso
Publikováno v:
Journal of Experimental & Clinical Cancer Research : CR
Background The role of second-line therapy in gastric cancer patients mostly stemmed from clinical trials with monochemotherapy carried out in Asian countries. Nevertheless, these results cannot be broadly generalized as molecular studies suggested t
Autor:
L. Di Lauro, M. G. Arena, G. Paoletti, Silvia Carpano, Franca Belli, Diana Giannarelli, M. Lopez
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 16(9)
Background: Docetaxel is a new agent with activity in metastatic gastric cancer. This phase II study was designed to evaluate the activity and safety of an epirubicin, cisplatin and docetaxel combination in patients with this disease. Patients and me
Autor:
Patrizia, Vici, Paolo, Foggi, Giuseppe, Colucci, Elisabetta, Capomolla, Mario, Brandi, Francesco, Giotta, Nicola, Gebbia, Luigi, Di Lauro, Maria Rosaria, Valerio, Giancarlo, Paoletti, Franca, Belli, Carmine, Pizza, Diana, Giannarelli, Massimo, Lopez
Publikováno v:
Anticancer research. 25(2B)
This phase II study evaluated the efficacy and the tolerability of a sequential regimen of docetaxel followed by epirubicin-vinorelbine combination as first-line chemotherapy in advanced breast cancer.Twenty-seven patients received docetaxel 100 mg/m
Autor:
Rosa, Sciuto, Rosella, Pasqualoni, Serenella, Bergomi, Germana, Petrilli, Patrizia, Vici, Franca, Belli, Claudio, Botti, Marcella, Mottolese, Carlo L, Maini
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 43(6)
This study evaluated the role of (99m)Tc-sestamibi washout in the prediction of pathologic tumor response to neoadjuvant chemotherapy in 30 patients with locally advanced breast cancer.Two (99m)Tc-sestamibi studies were performed before and after che
Autor:
Silvia Ileana Fattoruso, Domenico Sergi, Laura Pizzuti, M. G. Arena, Luigi Di Lauro, Patrizia Vici, Franca Belli
Publikováno v:
Journal of Clinical Oncology. 31:e15065-e15065
e15065 Background: So far, the prognosis of advanced gastric cancer is dismal. Combination chemotherapy of docetaxel (D), cisplatin (C) and fluorouracil (F) showed activity in metastatic gastric cancer, but this regimen was complicated by a high inci